Medical Transcription prices IPO at $5 as expected

Comment

Shutterstock photo

Medical Transcription Billing, which provides a SaaS platform for ambulatory care facilities, raised $20 million by offering 4.1 million shares at $5, its revised IPO price. The company initially filed to offer 3.0 million shares at a range of $9 to $11, but slashed its price to $5 and increased shares offered in an amendment filed last week.  Medical Transcription Billing will list on the NASDAQ under the symbol MTBC. Chardan Capital Markets, Aegis Capital and Summer Street Research Partners acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com